Haiyan Jiang

Investor

Scientific Advisory Group Member at Pathway to Cures

About

Jiang is co-founder and Chief Scientific Officer at PointLoma BioSciences, with deep experience in cell and gene therapy. She contributed to development of therapies at Editas Medicine, Biogen, and Bayer.

Colleagues at Pathway to Cures

Amy L. Dunn

Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures

Beth Whitehouse

NBDF Senior Vice President for Advancement at Pathway to Cures

Brian Andrew

Investment Committee Chair at Pathway to Cures

Christine Brennan

Investment Committee Member at Pathway to Cures

Geeta Vemuri

Managing Partner, Founder at Agent Capital

Gilbert C. White

P2C Board Vice Chair & Secretary at Pathway to Cures

Gilbert C. White, II

P2C Board Vice Chair & Secretary at Pathway to Cures

Glenn Pierce

Scientific Advisory Group Co-Chair at Pathway to Cures